We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

17 hedge funds and large institutions have $3.63M invested in Grace Therapeutics in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more funds holding

Funds holding: 14 → 17 (+3)

31% less capital invested

Capital invested by funds: $5.29M → $3.63M (-$1.67M)

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$61.5K
2
VKH
Virtu KCG Holdings
New York
+$46.3K
3
Citadel Advisors
Citadel Advisors
Florida
+$20.4K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$12.1K
5
Deutsche Bank
Deutsche Bank
Germany
+$738

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$1.29M – – –
Fiera Capital (Canada)
2
Fiera Capital (Canada)
Quebec, Canada
$808K – – –
IIM
3
Intact Investment Management
Quebec, Canada
$755K – – –
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$556K +$61.5K +250 +12%
1832 Asset Management
5
1832 Asset Management
Ontario, Canada
$85K – – –
VKH
6
Virtu KCG Holdings
New York
$82K +$46.3K +188 +123%
Citadel Advisors
7
Citadel Advisors
Florida
$20K +$20.4K +83 New
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$12K +$12.1K +49 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$9K – – –
UBS Group
10
UBS Group
Switzerland
$7K +$6.89K +28 New
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$2K – – –
CP
12
Corbenic Partners
Pennsylvania
$1K – – –
EWM
13
Edge Wealth Management
New York
$1K – – –
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1K – – –
Citigroup
15
Citigroup
New York
$1K +$492 +2 +200%
Deutsche Bank
16
Deutsche Bank
Germany
– +$738 +3 New

GRCE Hedge Fund Activity: Q4 2014 in Review

17 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q4 2014, worth a combined $3.63M — down 31% from $5.29M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new GRCE positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Bank of Montreal, adding an estimated $61.5K.

  • 17 institutional investors held Grace Therapeutics (GRCE) as of Q4 2014, up from 14 in Q3 2014.
  • Funds reported $3.63M of Grace Therapeutics stock for Q4 2014, down 31% quarter-over-quarter.
  • 4 funds opened new Grace Therapeutics positions in Q4 2014 and 0 closed out, a net change of +4 holders.
  • The largest Grace Therapeutics buyer in Q4 2014 was Bank of Montreal, an estimated $61.5K added.

Based on aggregated 13F filings for Q4 2014.